Non-Hodgkins

1 clinical trials · Condition

Record	Firm	Date
Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders (NCT00587054)	Memorial Sloan Kettering Cancer Center	2001-06-01

Every clearance here is in the API, with alerts when new ones post.